Tricarboxylate transport protein, mitochondrial

Last updated
SLC25A1
Identifiers
Aliases SLC25A1 , CTP, D2L2AD, SEA, SLC20A3, solute carrier family 25 member 1, CMS23
External IDs OMIM: 190315 HomoloGene: 136551 GeneCards: SLC25A1
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001256534
NM_001287387
NM_005984

n/a

RefSeq (protein)

NP_001243463
NP_001274316
NP_005975
NP_001243463.1
NP_001274316.1

Contents

n/a

Location (UCSC) Chr 22: 19.18 – 19.18 Mb n/a
PubMed search [2] n/a
Wikidata
View/Edit Human

Tricarboxylate transport protein, mitochondrial, also known as tricarboxylate carrier protein and citrate transport protein (CTP), is a protein that in humans is encoded by the SLC25A1 gene. [3] [4] [5] [6] SLC25A1 belongs to the mitochondrial carrier gene family SLC25. [7] [8] [9] High levels of the tricarboxylate transport protein are found in the liver, pancreas and kidney. Lower or no levels are present in the brain, heart, skeletal muscle, placenta and lung. [7] [9]

The tricarboxylate transport protein is located within the inner mitochondria membrane. It provides a link between the mitochondrial matrix and cytosol by transporting citrate through the impermeable inner mitochondrial membrane in exchange for malate from the cytosol. [7] [8] [9] [10] The citrate transported out of the mitochondrial matrix by the tricarboxylate transport protein is catalyzed by citrate lyase to acetyl CoA, the starting material for fatty acid biosynthesis, and oxaloacetate. [8] As well, cytosolic NADPH + H+ necessary for fatty acid biosynthesis is generated in the reduction of oxaloacetate to malate and pyruvate by malate dehydrogenase and the malic enzyme. [9] [11] [12] For these reasons, the tricarboxylate transport protein is considered to play a key role in fatty acid synthesis. [8]

Structure

A 3D cartoon depiction of the tripartite structure of a mitochondrial transport protein, generated from 23CE bovine mitochondrial ADP-ATP carrier Bovine mitochondrial ADP-ATP carrier 1.png
A 3D cartoon depiction of the tripartite structure of a mitochondrial transport protein, generated from 23CE bovine mitochondrial ADP-ATP carrier
A zoomed in image of the C and N termini and the two loops linking the repeated domains on the cytoplasmic side of the inner mitochondrial membrane. Bovine mitochondrial ADP-ATP carrier 2.png
A zoomed in image of the C and N termini and the two loops linking the repeated domains on the cytoplasmic side of the inner mitochondrial membrane.
A zoomed in image of the three loops linking the two a-helices of each repeated domain located on the matrix side of the membrane. Bovine mitochondrial ADP-ATP carrier 3.png
A zoomed in image of the three loops linking the two α-helices of each repeated domain located on the matrix side of the membrane.

The structure of the tricarboxylate transport protein is consistent with the structures of other mitochondrial carriers. [7] [8] [10] In particular, the tricarboxylate transport protein has a tripartite structure consisting of three repeated domains that are approximately 100 amino acids in length. [7] [10] Each repeat forms a transmembrane domain consisting of two hydrophobic α-helices. [7] [8] [13] The amino and carboxy termini are located on the cytosolic side of the inner mitochondrial membrane. [7] [8] Each domain is linked by two hydrophilic loops located on the cytosolic side of the membrane. [7] [8] [13] [14] The two α-helices of each repeated domain are connected by hydrophilic loops located on the matrix side of the membrane. [7] [8] [14] A salt bridge network is present on both the matrix side and cytoplasmic side of the tricarboxylate transport protein. [14]

Transport mechanism

The tricarboxylate transport protein exists in two states: a cytoplasmic state where it accepts malate from the cytoplasm and a matrix state where it accepts citrate from the mitochondrial matrix. [15] A single binding site is present near the center of the cavity of the tricarboxylate transport protein, which can be either exposed to the cytosol or the mitochondrial matrix depending on the state. [13] [14] [15] A substrate induced conformational change occurs when citrate enters from the matrix side and binds to the central cavity of the tricarboxylate transport protein. [7] This conformational change opens a gate on the cytosolic side and closes the gate on the matrix side. [7] Likewise, when malate enters from the cytosolic side, the matrix gate opens and the cytosolic gate closes. [7] Each side of the transporter is open and closed by the disruption and formation of the salt bridge networks, which allows access to the single binding site. [13] [14] [15] [16] [17]

Disease relevance

Mutations in this gene have been associated with the inborn error of metabolism combined D-2- and L-2-hydroxyglutaric aciduria, [18] which was the first reported case of a pathogenic mutation of the SLC25A1 gene. [14] [19] Patients with D-2/L-2-hydroxyglutaric aciduria display neonatal onset metabolic encephalopathy, infantile epilepsy, global developmental delay, muscular hypotonia and early death. [14] [19] [20] It is believed low levels of citrate in the cytosol and high levels of citrate in the mitochondria caused by the impaired citrate transport plays a role in the disease. [14] [20] In addition, increased expression of the tricarboxylate transport protein has been linked to cancer [9] [21] [22] and the production of inflammatory mediators. [23] [24] [25] Therefore, it has been suggested that inhibition of the tricarboxylate transport protein may have a therapeutic effect in chronic inflammation diseases and cancer. [24]

See also

Related Research Articles

<span class="mw-page-title-main">Respiratory complex I</span> Protein complex involved in cellular respiration

Respiratory complex I, EC 7.1.1.2 is the first large protein complex of the respiratory chains of many organisms from bacteria to humans. It catalyzes the transfer of electrons from NADH to coenzyme Q10 (CoQ10) and translocates protons across the inner mitochondrial membrane in eukaryotes or the plasma membrane of bacteria.

<span class="mw-page-title-main">Thermogenin</span> Mammalian protein found in Homo sapiens

Thermogenin is a mitochondrial carrier protein found in brown adipose tissue (BAT). It is used to generate heat by non-shivering thermogenesis, and makes a quantitatively important contribution to countering heat loss in babies which would otherwise occur due to their high surface area-volume ratio.

<span class="mw-page-title-main">Mitochondrial matrix</span> Space within the inner membrane of the mitochondrion

In the mitochondrion, the matrix is the space within the inner membrane. The word "matrix" stems from the fact that this space is viscous, compared to the relatively aqueous cytoplasm. The mitochondrial matrix contains the mitochondrial DNA, ribosomes, soluble enzymes, small organic molecules, nucleotide cofactors, and inorganic ions.[1] The enzymes in the matrix facilitate reactions responsible for the production of ATP, such as the citric acid cycle, oxidative phosphorylation, oxidation of pyruvate, and the beta oxidation of fatty acids.

<span class="mw-page-title-main">Inner mitochondrial membrane</span>

The inner mitochondrial membrane (IMM) is the mitochondrial membrane which separates the mitochondrial matrix from the intermembrane space.

<span class="mw-page-title-main">Phosphoenolpyruvate carboxykinase</span> Enzyme

Phosphoenolpyruvate carboxykinase is an enzyme in the lyase family used in the metabolic pathway of gluconeogenesis. It converts oxaloacetate into phosphoenolpyruvate and carbon dioxide.

<span class="mw-page-title-main">Mitochondrial membrane transport protein</span>

Mitochondrial membrane transport proteins, also known as mitochondrial carrier proteins, are proteins which exist in the membranes of mitochondria. They serve to transport molecules and other factors, such as ions, into or out of the organelles. Mitochondria contain both an inner and outer membrane, separated by the inter-membrane space, or inner boundary membrane. The outer membrane is porous, whereas the inner membrane restricts the movement of all molecules. The two membranes also vary in membrane potential and pH. These factors play a role in the function of mitochondrial membrane transport proteins. There are 53 discovered human mitochondrial membrane transporters, with many others that are known to still need discovered.

<span class="mw-page-title-main">Adenine nucleotide translocator</span> Class of transport proteins

Adenine nucleotide translocator (ANT), also known as the ADP/ATP translocase (ANT), ADP/ATP carrier protein (AAC) or mitochondrial ADP/ATP carrier, exchanges free ATP with free ADP across the inner mitochondrial membrane. ANT is the most abundant protein in the inner mitochondrial membrane and belongs to mitochondrial carrier family.

<span class="mw-page-title-main">Glycerol phosphate shuttle</span>

The glycerol-3-phosphate shuttle is a mechanism used in skeletal muscle and the brain that regenerates NAD+ from NADH, a by-product of glycolysis. The NADH generated during glycolysis is found in the cytoplasm and must be transported into the mitochondria to enter the oxidative phosphorylation pathway. However, the inner mitochondrial membrane is impermeable to NADH and NAD+ and does not contain a transport system for these electron carriers. Either the glycerol-3-phosphate shuttle pathway or the malate-aspartate shuttle pathway, depending on the tissue of the organism, must be taken to transport cytoplasmic NADH into the mitochondria. The shuttle consists of the sequential activity of two proteins; Cytoplasmic glycerol-3-phosphate dehydrogenase (cGPD) transfers an electron pair from NADH to dihydroxyacetone phosphate (DHAP), forming glycerol-3-phosphate (G3P) and regenerating NAD+ needed to generate energy via glycolysis. The other protein, mitochondrial glycerol-3-phosphate dehydrogenase (mGPD) catalyzes the oxidation of G3P by FAD, regenerating DHAP in the cytosol and forming FADH2 in the mitochondrial matrix. In mammals, its activity in transporting reducing equivalents across the mitochondrial membrane is considered secondary to the malate-aspartate shuttle.

<span class="mw-page-title-main">Mitochondrial carrier</span>

Mitochondrial carriers are proteins from solute carrier family 25 which transfer molecules across the membranes of the mitochondria. Mitochondrial carriers are also classified in the Transporter Classification Database. The Mitochondrial Carrier (MC) Superfamily has been expanded to include both the original Mitochondrial Carrier (MC) family and the Mitochondrial Inner/Outer Membrane Fusion (MMF) family.

<span class="mw-page-title-main">Citrin</span> Mammalian protein found in humans

Citrin, also known as solute carrier family 25, member 13 (citrin) or SLC25A13, is a protein which in humans is encoded by the SLC25A13 gene.

<span class="mw-page-title-main">GOT2</span> Mitochondrial enzyme involved in amino acid metabolism

Aspartate aminotransferase, mitochondrial is an enzyme that in humans is encoded by the GOT2 gene. Glutamic-oxaloacetic transaminase is a pyridoxal phosphate-dependent enzyme which exists in cytoplasmic and inner-membrane mitochondrial forms, GOT1 and GOT2, respectively. GOT plays a role in amino acid metabolism and the urea and Kreb's cycle. Also, GOT2 is a major participant in the malate-aspartate shuttle, which is a passage from the cytosol to the mitochondria. The two enzymes are homodimeric and show close homology. GOT2 has been seen to have a role in cell proliferation, especially in terms of tumor growth.

<span class="mw-page-title-main">SFXN1</span> Protein-coding gene in the species Homo sapiens

Sideroflexin-1 is a protein that in humans is encoded by the SFXN1 gene. According to Nora Kory et al., SFXN1 gene product has mitochondrial serine transporter activity.

<span class="mw-page-title-main">Mitochondrial 2-oxoglutarate/malate carrier protein</span> Mammalian protein found in Homo sapiens

Mitochondrial 2-oxoglutarate/malate carrier protein is a protein that in humans is encoded by the SLC25A11 gene. Inactivating mutations in this gene predispose to metastasic paraganglioma.

<span class="mw-page-title-main">Mitochondrial dicarboxylate carrier</span> Mammalian protein found in Homo sapiens

The mitochondrial dicarboxylate carrier (DIC) is an integral membrane protein encoded by the SLC25A10 gene in humans that catalyzes the transport of dicarboxylates such as malonate, malate, and succinate across the inner mitochondrial membrane in exchange for phosphate, sulfate, and thiosulfate by a simultaneous antiport mechanism, thus supplying substrates for the Krebs cycle, gluconeogenesis, urea synthesis, fatty acid synthesis, and sulfur metabolism.

<span class="mw-page-title-main">Calcium-binding mitochondrial carrier protein Aralar1</span> Protein-coding gene in the species Homo sapiens

Calcium-binding mitochondrial carrier protein Aralar1 is a protein that in humans is encoded by the SLC25A12 gene. Aralar is an integral membrane protein located in the inner mitochondrial membrane. Its primary function as an antiporter is the transport of cytoplasmic glutamate with mitochondrial aspartate across the inner mitochondrial membrane, dependent on the binding of one calcium ion. Mutations in this gene cause early infantile epileptic encephalopathy 39 (EIEE39), symptomized by global hypomyelination of the central nervous system, refractory seizures, and neurodevelopmental impairment. This gene has connections to autism.

<span class="mw-page-title-main">ADP/ATP translocase 4</span> Protein-coding gene in the species Homo sapiens

ADP/ATP translocase 4 (ANT4) is an enzyme that in humans is encoded by the SLC25A31 gene on chromosome 4. This enzyme inhibits apoptosis by catalyzing ADP/ATP exchange across the mitochondrial membranes and regulating membrane potential. In particular, ANT4 is essential to spermatogenesis, as it imports ATP into sperm mitochondria to support their development and survival. Outside this role, the SLC25AC31 gene has not been implicated in any human disease.

Pyruvate cycling commonly refers to an intracellular loop of spatial movements and chemical transformations involving pyruvate. Spatial movements occur between mitochondria and cytosol and chemical transformations create various Krebs cycle intermediates. In all variants, pyruvate is imported into the mitochondrion for processing through part of the Krebs cycle. In addition to pyruvate, alpha-ketoglutarate may also be imported. At various points, the intermediate product is exported to the cytosol for additional transformations and then re-imported. Three specific pyruvate cycles are generally considered, each named for the principal molecule exported from the mitochondrion: malate, citrate, and isocitrate. Other variants may exist, such as dissipative or "futile" pyruvate cycles.

<span class="mw-page-title-main">Calcium-binding mitochondrial carrier protein SCaMC-1</span> Protein-coding gene in the species Homo sapiens

Calcium-binding mitochondrial carrier protein SCaMC-1 is a protein that in humans is encoded by the SLC25A24 gene.

The ion transporter (IT) superfamily is a superfamily of secondary carriers that transport charged substrates.

<span class="mw-page-title-main">Citrate–malate shuttle</span>

The citrate-malate shuttle is a series of chemical reactions, commonly referred to as a biochemical cycle or system, that transports acetyl-CoA in the mitochondrial matrix across the inner and outer mitochondrial membranes for fatty acid synthesis. Mitochondria are enclosed in a double membrane. As the inner mitochondrial membrane is impermeable to acetyl-CoA, the shuttle system is essential to fatty acid synthesis in the cytosol. It plays an important role in the generation of lipids in the liver.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000100075 - Ensembl, May 2017
  2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. Heisterkamp N, Mulder MP, Langeveld A, ten Hoeve J, Wang Z, Roe BA, Groffen J (September 1995). "Localization of the human mitochondrial citrate transporter protein gene to chromosome 22Q11 in the DiGeorge syndrome critical region". Genomics. 29 (2): 451–6. doi:10.1006/geno.1995.9982. PMID   8666394.
  4. Iacobazzi V, Lauria G, Palmieri F (September 1997). "Organization and sequence of the human gene for the mitochondrial citrate transport protein". DNA Sequence. 7 (3–4): 127–39. doi:10.3109/10425179709034029. PMID   9254007.
  5. Dolce V, Cappello AR, Capobianco L (September 1997). "Mitochondrial tricarboxylate and dicarboxylate-tricarboxylate carriers: from animals to plants". IUBMB Life. 66 (7): 462–71. doi: 10.1002/iub.1290 . PMID   25045044.
  6. "Entrez Gene: SLC25A1 solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1".
  7. 1 2 3 4 5 6 7 8 9 10 11 12 Palmieri F (April 2013). "The mitochondrial transporter family SLC25: identification, properties and physiopathology". Molecular Aspects of Medicine. 34 (2–3): 465–84. doi:10.1016/j.mam.2012.05.005. PMID   23266187.
  8. 1 2 3 4 5 6 7 8 9 Palmieri F (February 2004). "The mitochondrial transporter family (SLC25): physiological and pathological implications". Pflügers Archiv. 447 (5): 689–709. doi:10.1007/s00424-003-1099-7. PMID   14598172. S2CID   25304722.
  9. 1 2 3 4 5 Iacobazzi V, Infantino V, Palmieri F (January 2013). "Transcriptional Regulation of the Mitochondrial Citrate and Carnitine/Acylcarnitine Transporters: Two Genes Involved in Fatty Acid Biosynthesis and β-oxidation". Biology. 2 (1): 284–303. doi: 10.3390/biology2010284 . PMC   4009865 . PMID   24832661.
  10. 1 2 3 Berg JM, Tymoczko JL, Gatto GJ, Stryer L (2015). Biochemistry. New York: W.H. Freeman & Company. p. 551. ISBN   978-1-4641-2610-9.
  11. Voet D, Voet JG, Pratt CW (2016). Fundamentals of Biochemistry. U.S.A.: Wiley. pp. 687–688. ISBN   978-1-118-91840-1.
  12. Nelson DL, Cox MM (2017). Principles of Biochemistry. New York: W.H. Freeman & Company. pp. 818–819. ISBN   978-1-4641-2611-6.
  13. 1 2 3 4 King MS, Kerr M, Crichton PG, Springett R, Kunji ER (January 2016). "Formation of a cytoplasmic salt bridge network in the matrix state is a fundamental step in the transport mechanism of the mitochondrial ADP/ATP carrier". Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1857 (1): 14–22. doi:10.1016/j.bbabio.2015.09.013. PMC   4674015 . PMID   26453935.
  14. 1 2 3 4 5 6 7 8 Majd H, King MS, Smith AC, Kunji ER (January 2018). "Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis". Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1859 (1): 1–7. doi: 10.1016/j.bbabio.2017.10.002 . PMID   29031613.
  15. 1 2 3 Robinson AJ, Kunji ER (February 2006). "Mitochondrial carriers in the cytoplasmic state have a common substrate binding site". Proceedings of the National Academy of Sciences of the United States of America. 103 (8): 2617–22. Bibcode:2006PNAS..103.2617R. doi: 10.1073/pnas.0509994103 . PMC   1413793 . PMID   16469842.
  16. Robinson AJ, Overy C, Kunji ER (November 2008). "The mechanism of transport by mitochondrial carriers based on analysis of symmetry". Proceedings of the National Academy of Sciences of the United States of America. 105 (46): 17766–71. Bibcode:2008PNAS..10517766R. doi: 10.1073/pnas.0809580105 . PMC   2582046 . PMID   19001266.
  17. Kunji ER, Robinson AJ (September 2006). "The conserved substrate binding site of mitochondrial carriers". Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1757 (9–10): 1237–48. doi: 10.1016/j.bbabio.2006.03.021 . PMID   16759636.
  18. Nota B, Struys EA, Pop A, Jansen EE, Fernandez Ojeda MR, Kanhai WA, Kranendijk M, van Dooren SJ, Bevova MR, Sistermans EA, Nieuwint AW, Barth M, Ben-Omran T, Hoffmann GF, de Lonlay P, McDonald MT, Meberg A, Muntau AC, Nuoffer JM, Parini R, Read MH, Renneberg A, Santer R, Strahleck T, van Schaftingen E, van der Knaap MS, Jakobs C, Salomons GS (April 2013). "Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria". American Journal of Human Genetics. 92 (4): 627–31. doi:10.1016/j.ajhg.2013.03.009. PMC   3617390 . PMID   23561848.
  19. 1 2 Hoffmann GF, Köckler S (2016). "Cerebral Organic Acid Disorders and Other Disorders of Lysine Catabolism". In Saudubray JM, Baumgartner M, Walter J (eds.). Inborn Metabolic Diseases. Germany: Springer. p. 344. ISBN   978-3-662-49771-5.
  20. 1 2 Cohen I, Staretz-Chacham O, Wormser O, Perez Y, Saada A, Kadir R, Birk OS (February 2018). "A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion". American Journal of Medical Genetics. Part A. 176 (2): 330–336. doi:10.1002/ajmg.a.38574. PMID   29226520. S2CID   6953669.
  21. Jiang L, Boufersaoui A, Yang C, Ko B, Rakheja D, Guevara G, Hu Z, DeBerardinis RJ (September 2017). "Quantitative metabolic flux analysis reveals an unconventional pathway of fatty acid synthesis in cancer cells deficient for the mitochondrial citrate transport protein". Metabolic Engineering. 43 (Pt B): 198–207. doi:10.1016/j.ymben.2016.11.004. PMC   5429990 . PMID   27856334.
  22. Wan-angkan, P.; et al. (2018). "Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells". BioMed Research International. 2018: 3683026. doi: 10.1155/2018/3683026 . PMC   5818947 . PMID   29546056.
  23. Infantino V, Convertini P, Cucci L, Panaro MA, Di Noia MA, Calvello R, Palmieri F, Iacobazzi V (September 2011). "The mitochondrial citrate carrier: a new player in inflammation". The Biochemical Journal. 438 (3): 433–6. doi:10.1042/BJ20111275. hdl: 11563/18487 . PMID   21787310.
  24. 1 2 Infantino V, Iacobazzi V, Menga A, Avantaggiati ML, Palmieri F (November 2014). "A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation". Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1839 (11): 1217–1225. doi:10.1016/j.bbagrm.2014.07.013. PMC   4346166 . PMID   25072865.
  25. Palmieri EM, Spera I, Menga A, Infantino V, Porcelli V, Iacobazzi V, Pierri CL, Hooper DC, Palmieri F, Castegna A (August 2015). "Acetylation of human mitochondrial citrate carrier modulates mitochondrial citrate/malate exchange activity to sustain NADPH production during macrophage activation". Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1847 (8): 729–38. doi: 10.1016/j.bbabio.2015.04.009 . PMID   25917893.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.